Hemodialysis Technology Company Diality Names Robert Funari to its Board of Directors
Retrieved on:
Wednesday, May 31, 2023
Diality Inc. , a medical technology company developing a smart, flexible hemodialysis platform, today announced the appointment of healthcare veteran Robert Funari to its board of directors.
Key Points:
- Diality Inc. , a medical technology company developing a smart, flexible hemodialysis platform, today announced the appointment of healthcare veteran Robert Funari to its board of directors.
- Funari has spent nearly 50 years in the healthcare industry in public and privately held companies, in both services and medical devices.
- He was chairman of hemodialysis technology company NxStage Medical until its 2019 acquisition by Fresenius Medical Care.
- “We thank Aaron for his dedicated service at Diality, and wish him well in his future endeavors,” Khawar said.